Researchers at Baylor College of Medicine, the Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital, the Texome Project and collaborating institutions have identified variants in the BRSK1 gene as a likely diagnosis for individuals with a rare and complex neurodevelopmental disorder who had not received an explanation for their condition.